RET AND TRK PROTOONCOGENE ACTIVATION IN THYROID PAPILLARY CARCINOMAS IN FRENCH PATIENTS FROM THE CHAMPAGNE-ARDENNE REGION

Citation
C. Delvincourt et al., RET AND TRK PROTOONCOGENE ACTIVATION IN THYROID PAPILLARY CARCINOMAS IN FRENCH PATIENTS FROM THE CHAMPAGNE-ARDENNE REGION, Clinical biochemistry, 29(3), 1996, pp. 267-271
Citations number
28
Categorie Soggetti
Biology,"Chemistry Medicinal
Journal title
ISSN journal
00099120
Volume
29
Issue
3
Year of publication
1996
Pages
267 - 271
Database
ISI
SICI code
0009-9120(1996)29:3<267:RATPAI>2.0.ZU;2-C
Abstract
Objectives: To investigate the presence of ret and trk protooncogene r earrangements in thyroid tumors. Design and Methods: High-molecular-we ight DNA was extracted from 36 thyroid tumors (1 multinodular goiter, 14 follicular adenomas, 16 papillary carcinomas, 1 lymph node metastas is of a papillary carcinoma, 1 follicular carcinoma, and 3 medullary c arcinomas) and 22 adjacent tissues. Southern blot analysis was perform ed after digestion with EcoR1 or BamH1, using specific probes for ret and trk. Results: Only 2 ret rearrangements were found in 2 papillary carcinomas (overall frequency: 6%; papillary carcinoma frequency: 13%) . All normal or tumor samples were negative for the presence of a trk rearrangement. Conclusions: The previous data from the literature are highly conflicting, ranging from 0 to 30% of activation. Our results c ould be, therefore, classified as medium between these extreme values. It seems, therefore, that genetic and/or geographical factors could p lay a role in ret and trk proto-oncogene activation.